EXPRESSION OF P38MAP KINASE IN EPITHELIAL OVARIAN CARCINOMA

被引：0
|
作者：
Laterza, F. [1 ]
Caringella, A. M. [1 ]
Marrano, T. [1 ]
Stella, M. [1 ]
Di Naro, E. [1 ]
Loverro, G. [1 ]
机构：
[1] Policlin Bari, Bari, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP
    Richard Carroll
    Derek M. Yellon
    Basic Research in Cardiology, 2000, 95 : 243 - 249
  • [22] Pseudomonas aeruginosa induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway
    Coates, Matthew S.
    Alton, Eric W. F. W.
    Rapeport, Garth W.
    Davies, Jane C.
    Ito, Kazuhiro
    PLOS ONE, 2021, 16 (02):
  • [23] Tri- and Tetrasubstituted Pyrazole Derivates: Regioisomerism Switches Activity from p38MAP Kinase to Important Cancer Kinases
    Abu Thaher, Bassam
    Arnsmann, Martina
    Totzke, Frank
    Ehlert, Jan E.
    Kubbutat, Michael H. G.
    Schaechtele, Christoph
    Zimmermann, Markus O.
    Koch, Pierre
    Boeckler, Frank M.
    Laufer, Stefan A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 961 - 965
  • [24] Delayed cardioprotection in a human cardiomyocyte-derived cell line:: the role of adenosine, p38MAP kinase and mitochondrial KATP
    Carroll, R
    Yellon, DM
    BASIC RESEARCH IN CARDIOLOGY, 2000, 95 (03) : 243 - 249
  • [25] HPV and p53 expression in epithelial ovarian carcinoma
    Kuscu, E
    Ozdemir, BH
    Erkanli, S
    Haberal, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (06) : 642 - 645
  • [26] Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase
    Nofer, JR
    Noll, C
    Feuerborn, R
    Assmann, G
    Tepel, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (03) : 751 - 757
  • [27] P38 MAP kinase expression and activation in smooth muscle.
    Hedqes, JC
    Yamboliev, IA
    Horowitz, B
    Adam, LP
    Gerthoffer, WT
    FASEB JOURNAL, 1998, 12 (04): : A449 - A449
  • [28] Activation of P38MAP kinase in estrogen-positive invasive breast cancers: Relation with HER2 and downstream signaling phosphorylated proteins expression.
    Merlin, Jean-Louis
    Harle, Alexandre
    Lion, Maeva
    Chretien, Anne-Sophie
    Ramacci, Carole
    Leroux, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Inhibitors of p38α MAP kinase
    Chakravarty, S
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 177 - 186
  • [30] The pharmacokinetics (PK) and pharmacodynamics (PD) of VX-702, a novel, oral p38MAP kinase inhibitor, in healthy volunteers.
    Godfrey, C
    Mohanlal, R
    Merica, E
    Ette, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P52 - P52
12345